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The development of quantitative in vitro methods for the analysis of various medi- 
ators of the inflammatory response has led to a greater understanding of the functions 
of such mediators. Indeed, recent investigations have suggested that the complement 
(C) ~  system plays a central role as an effector of a number of events in the inflamma- 
tory process  (1, 2). A point which has emerged from various in vitro studies, however, 
is that there are a  multiplicity of mediators for  any given biological function. For 
example, fragmentation products from each of  the complement, clotting, and kinin 
systems have been reported to increase vascular permeability, contract smooth mus- 
cle, and chemotactically attract polymorphonuclear  leukocytes (PMN) (3). Important 
questions for future investigations  will be aimed at determining the relative quantita- 
tive and qualitative importance in vivo of each of the known biological effectors  in 
mediating any given aspect of the inflammatory process. 
A cardinal event in the acute inflammatory response is the accumulation of PMN 
at the inflammatory site. While we have previously discussed the importance of the 
fifth component of C (C5)  in the generation of PMN, as well as mononuclear leuko- 
cyte chemotactic activity in vitro (4, 5), information  on the role C5 plays in mediating 
the local accumulation of leukocytes in vivo is quite sparse. In this report, data will 
be presented which suggest an important role for C5  in the early accumulation of 
PMN in inflammatory exudates. 
Materials  and Methods 
Animals.--Hartley-strain albino male guinea pigs were obtained from the Animll Resources 
Branch of the National Institutes of Health. Male mice of the lines B10D2/SN  "new" (C5- 
normal) and B10D2/SN "old" (C5-deficient) (6) were purchased from Jackson Laboratories, 
Bar Harbor, Maine. 
Inflammatory Stimulants.--SheUfish  glycogen (Mann Research Labs. Inc., New York) was 
used at a final concentration of 0.5%  (w/v)  in pyrogen-free saline. Endotoxin derived from 
I Abbreviations used in this paper: BSA, bovine serum albumin; C, complement; CS-defi- 
cient, B10D2/SN  "old"; C5-normal, B10D2/SN "new"; GVB, gelatin Veron~l buffer; PBS, 
phosphate-buffered saline; PMN, polymorphonuclear leukocytes. 
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Salmondla  typhosa 0901 (Difco Laboratories, Detroit, Mich.) was used in varying concentra- 
tions where indicated. 
Antiserum.--Rabbit  antiserum to highly purified guinea pig C5  (120 ug antibody N/ml) 
was generously provided by Dr. Hyun S. Shin. 
Inflammatory Exudates.-- 
(a)  Glycogen-induced guinea pig  exudales:  Guinea  pigs  were  injected intraperitoneally 
with 30 ml of glycogen solution. At various times thereafter, the animals were sacrificed  by 
cervical dislocation and  the peritoneal cavity was exposed by an abdominal incision.  The 
exudates were collected and immediately stored at 0°C. The peritoneal cavity was then washed 
with 0.005 M disodium ethylenediaminetetraacetate (EDTA) in saline  (pH 7.4) to bring the 
total volume of recovered exudate to 40 mL The exudates were centrifuged at 0°C for i0 min 
at 900 g. The supernatant was recentrifuged at 0°C for 30 min at 28,000 g and the resultant 
supernatant was assayed for chemotactic activity. The sediment of the first centrifugation 
was resuspended in 1.0 ml Gey's medium (7)  and the total and differential white blood cell 
counts were determined. 
(b)  Endotoxin-induced guinea pig  exudates:  Guinea pigs were injected intraperltoneally 
with 5.0 m] of pyrogen-free saline containing 500/~g  endotoxin. The animals were sacrificed 
at various times thereafter and the exudates were processed in the same manner as the gly- 
cogen-induced exudates. 
(c) Endotoxin4nduced peritoneal exudates in mice:  C5-normal and C5-deficient mice were 
injected intraperitoneally with 2.0  ml pyrogen-free saline containing varying quantities of 
endotoxin (50-500  #g). At varying times thereafter, mice were sacrificed  by CO2 asphyxia- 
tion. The peritoneal cavities were exposed by abdominal incision and the exudates were re- 
moved and immediately stored at 0°C. The peritoneal cavities were then washed with suffi- 
cient EDTA saline to bring the total volume recovered to 5.0 ml. The exudates were then 
processed in the same manner as the glycogen-induced exudates from guinea pigs. 
Chemotaxis Assays--Various materials were tested for in vitro chemotactic activity using 
a  modification (7, 8)  of the method developed by Boyden (9).  Chemotaxis chambers were 
purchased from Neuroprobe, Inc.  (Cabin John, Md.). In experiments where guinea pig exu- 
dates or fractions thereof were tested for chemotactic activity, rabbits served as the source of 
PMN and  1.2-/2 nitrocellulose filters  (Brinkman Instruments Inc., Westbury, N.  Y.)  were 
used in the chemotaxis chambers. In experiments where mouse peritoneal exudates, mouse 
serum, or mouse PMN were tested, PMN from peripheral blood were used and were obtained 
as follows.  Mice of the strains BALB/c, B10D2/SN "old," or B10D2/SN "new" were bled 
by cardiac puncture into syringes containing heparin (final concentration of heparin approxi- 
mately 250 units/ml blood). The mouse blood was mixed with an equal volume of 3%  (w/v) 
dextran  (250,000 tool wt)  in normal saline.  The erythrocytes were allowed to sediment for 
30-60 min at room temperature and the leukocyte-rich  plasma was withdrawn. The leukocyte- 
rich plasma was then centrifuged at 500 g for I0 rain. Contaminating erythrocytes in the sedi- 
ment were removed by hypotonic shock (0.2% NaC1 for 20 sec followed by 1.6% NaC1). The 
leukocytes were washed in Gey's medium and resuspended in Gey's medium to a final con- 
centration of 2.2  X  106 PMN/ml. 
Molecular Sieve Fractionation of Exudates.--Sephadex  G-100  (Pharmacia Fine Chemicals, 
Uppsala, Sweden) was used as the chromatographic medium in columns of 2.5 X  50 cm. Phos- 
phate (0.02 ~t)-buffered  (pH 7.2) isotonic saline (PBS) was used as the eluent. Exudates were 
dialyzed against at least 5000 times their volume with distilled water at 4°C for at least 16 hr. 
The dialyzed exudates were then dried from the frozen state and resolubilized  in an amount of 
pyrogen-free saline to give six times the original concentration of exudate. The concentrated 
exudate was then applied to the chromatographic medium. R.  SNYDERMAN,  J,  K.  PHILLIPS~  AND  S.  E.  MERGENtIAGEN  1133 
RESULTS 
Generation of Chemotactic Activity for Rabbit PMN in Guinea Pig Peritoneal 
Exudates.--Glycogen  has  long  been  known  to  induce  sterile  inflammatory 
exudates when instilled in the peritoneal cavities of a number of animal species 
(10).  Indeed,  this  technique  has  commonly been  used  to  obtain  the  PMN 
needed for in vitro chemotaxis assays  (9).  Peritoneal fluids were  taken from 
guinea  pigs  at  various  times  after  intraperitoneal  glycogen injection.  The 
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FIG.  1.  Accumulation of PMN  and  chemotactic activity for PMN  in  the peritoneal 
cavity of guinea pigs treated with glycogen. Guinea pigs were injected intraperitoneally with 
glycogen  solution (0.5%) and the peritoneal fluids were removed at the indicated times. Fluids 
of three guinea pigs for each time were pooled and assayed for total numbers of PMN as well 
as for in vitro chemotactic  activity for rabbit PMN. 
fluids were tested  in vitro for the presence of chemotactic activity for PMN 
as well as for total number of PMN which had accumulated in the peritoneal 
cavity. For up  to 2 hr  after injection of glycogen into the peritoneal  cavity 
there  was no significant increase  in  the  total  number  of accumulated PMN 
(Fig. 1). From the 2nd to the 24th hr, however, the number of PMN markedly 
increased and then slowly began decreasing in numbers  over the next 48 hr. 
It should be noted that before the influx of PMN the appearance occurred in 
the  peritoneal  fluid  of  activity which  was  chemotactic for  rabbit  PMN  in 
vitro  (Fig.  1).  Such activity could be detected within 30 rain  after glycogen 
injection  and  increased  in  amount until  the  numbers  of  accumulated PMN 
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In  another  experiment,  endotoxin,  rather  than  glycogen, was  used  as  the 
inflammatory stimulant and was injected into the peritoneal cavities of guinea 
pigs.  Endotoxin,  like  glycogen,  generated  PMN  chemotactic  activity  in 
peritoneal fluids followed by an increase in the number of accumulated PMN. 
In  the  case  of  endotoxin-induced  exudates  however,  significant  numbers  of 
PMN did not accumulate until 6 hr after injection. 
Characterization of Chemotactic Activity  Derived from Guinea Pig Peritoneal 
Exudates.--Animals  were  injected  intraperitoneally  with  endotoxin  and  the 
peritoneal  fluids were collected at varying  times  thereafter.  The pooled peri- 
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Fic.  2.  Characterization,  by molecular sieve chromatography,  of chemotactic  activity 
in supernatants  derived from' endotoxin-induced guinea pig peritoneal  exudate.  Endotoxin 
(500/zg) was injected intraperitoneally  into three guinea pigs and the peritoneal fluids were 
removed and pooled 6 hr thereafter. The exudate was concentrated  sixfold and applied to a 
2.5 X 50 cm Sephadex G-100 column which had previously been calibrated with BSA (mol wt 
68,000) and cytochrorne c (tool wt 12,500). PBS served as the elution buffer. Fractions  were 
tested for absorbance (OD) at 280 m/z and for chemotactic activity for rabbit  PMN in vitro. 
toneal  fluids from three guinea  pigs were  collected 6  hr  after  injection,  con- 
centrated  six  times,  and  applied  to  a  Sephadex  G-100  column  which  had 
previously been calibrate~d with markers  of known molecular weight (tool wt) 
(Fig. 2). Two peaks of chemotactic activity were found. The heavier molecular 
weight  peak  eluted  just  before  a  bovine serum  albumin  marker  (BSA)  (tool 
wt 68,000).  The lighter  molecular weight peak eluted  slightly ahead  of cyto- 
chrome c (tool wt 12,500)  and contained the majority of chemotactic activity 
present  in  the  exudate.  In  other  chromatograms  of exudates  taken  at  times 
ranging from 1 to 6 hr after injection of endotoxin the heavy molecular weight 
peak of chemotatic activity was variable  in amount.  Its activity was usually 
only  barely  detectable  but  occasionally  almost  equalled  the  low  molecular 
weight  activity.  On  the  other  hand,  the  low  molecular  weight  chemotactic 
activity  was  present  in  all  cases  and  always  accounted  for  the  majority  of R.  SNYDERMAN,  J.  K.  PHILLIPS,  AND  S.  E.  MERGENHAGEN  1135 
activity in  each  chromatographic separation.  In  addition  to  molecular sieve 
chromatography, concentrated  exudates  taken  at  varying times  after  endo- 
toxin injection were fractionated by sucrose-density gradient ultracentrifuga- 
tion  (10-30%  linear  sucrose  gradient  at  150,000  g  for  18  hr).  Exudates 
were  taken  from zero to 6  hr  after  injection.  In  these  experiments,  marked 
chemotactic activity sedimenting with a cytochrome c marker appeared within 
30 min after endotoxin injection and persisted for 6 hr.  Chemotactic activity 
sedimenting just ahead of BSA was found only in a 3 hr exudate and accounted 
for less than 50% of the activity found in the lighter fractions. 
To determine  if  the  chemotactic activity generated in  peritoneal  exudates 
was antigenically related  to  C5  (11,  12),  the  low  molecular  weight  activity 
TABLE I 
Inhibition by Antibody to C5 of Chemotactic Activity Deri~.ed  from 
Endotoxin-lnduced Guinea Pig Exudate 
Agents tested for chemotaxis* 
Cells per high power field 
Exp. 1  Exp. 2  Exp. 3  Exp. 4 
15,000 mol wt peak alone  156  60  103  71 
15,000 mol wt peak +  0.025 ml anti-C5  13  1  2  1 
15,000 mol wt peak +  0.025 ml anti-BSA  168  155  324  182 
* The 15,000 mol wt peak of chemotactic activity was isolated by Sephadex chromatog- 
raphy. Fractions (0.7 ml) of the peak of activity were reacted (37°C for 15 rain) alone or with 
the indicated volume of preheated (56°C for 30 rain) rabbit antiserum to guinea pig C5 or to 
BSA. The reaction mixtures were then brought to 1.7 ml with Gey's medium and tested for 
chemotactic activity. 
was isolated on a Sephadex G-100 column from a pooled 1 hr glycogen-induced 
exudate.  Portions  of  the  peak  of  this  low  molecular  weight  activity  were 
reacted (37°C for 15 rain) with rabbit antiserum to highly purified guinea pig 
C5  before  testing  for  chemotactic  activity  (Table  I).  The  data  indicated 
that the low molecular weight chemotactic factor derived from the inflammatory 
exudates was similar to C5a not only in terms of molecular weight but also in 
antigenic determinants. 
Ability of PMN from CS-Deficient  and C5-Normal Mice to Respond to Chemo- 
tactic Factor In Vitro.--To study the role of C5 in the kinetics of PMN accumu- 
lation  in  vivo it  was  necessary to  determine  if  the  PMN  from  C5-defieient 
animals behaved normally in vitro in response to preformed chemotactic factor. 
PMN were obtained from the peripheral blood of C5-deficient and C5-normal 
mice and were  tested for their  ability to respond to the chemotactic activity 
generated in C5-normal mouse serum by endotoxin (Table II). The data indi- 
cated that PMN from both groups of mice responded equally well  to chemo- 
tactic activity in vitro. Thus any differences in the kinetics of PMN accumula- 1136  BIOLOGICAL ACTIVITY OF  COMPLEMENT  IN  VIVO 
tion  in  vivo in  either  group  of mice would  not  be  expected  to  be  a  result  of 
differences in the responsiveness of their PMN  to chemotactic factor. 
Inability  to  Generate  Chemotactic  Activity  in  C5-Deficient  Mouse  Serum.- 
Serum  derived  from  CS-deficient  or C5-normal  mice  was  reacted  (37°C  for 
TABLE  II 
Chemotactic Response* In Vitro of PMN from C5-Defieient and CS-Normal Mice 
Reagent Tested~  C5-deficient  CS-normal PMN  PMN 
Normal mouse serum (0.2 ml)  3  30 
Normal mouse serum (0.1 ml)  -b endotoxin (200 #g)  108  128 
Normal mouse serum (0.2 ml) -[- endotoxin (200/zg)  300  228 
* Expressed as cells per high power field. 
:~ The indicated amount of normal mouse serum was reacted (37°C for 60 min followed by 
56°C for 30 rain) with 0.1  ml normal saline or with the indicated amount of endotoxin con- 
tained  in 0A  ml normal saline.  The reaction mixtures were brought  to  1.7  ml with Gey's 
medium  then  tested  for chemotactic activity using PMN  from either C5-deficient or C5- 
normal mice. 
TABLE  III 
Comparison of Chemotactic Activity* Generation in the Serum  of C5-Deficlent and 
C5-Normat Mice 
Reagent tested~  CS-deficlent  CS-normal 
serum  serum 
Serum alone 
Serum ~- BSA anti-BSA (50/~g AbN§) 
Serum q- BSA anti-BSA (100 #g AbN) 
Serum -F BSA anti-BSA (400 #g AbN) 
Serum -t- endotoxin (50 #g) 
Serum -k endotoxin (200/~g) 
5  43 
19  168 
12  273 
36  420 
10  480 
2  480 
* Expressed  as  cells per  high  power  field. 
Serum  (0.05  ml) from either C5-deficient or C5-normal mice was treated  (37°C for 60 
min) with 0.95 ml gelatin Veronal buffer supplemented with calcium and magnesium (GVB++), 
or GVB ++ containing the indicated amount of rabbit BSA anti-BSA immune precipitate made 
at  equivalence,  or  endotoxin.  The  reaction  mixtures were  brought  to  1.7  ml with  Gey's 
medium  and  tested  for  chemotactic  activity. 
§ AbN, antibody nitrogen. 
60 rain)  with varying amounts  of immune  precipitates or  endotoxin  and  then 
was tested for the presence  of chemotactic  activity in vitro for normal mouse 
PMN  (Table  III).  The  data  indicated that  mouse  serum  deficient in C5  was 
also  deficient  in  its  capability  to  generate  chemotactic  activity  for  mouse 
peripheral  PMN.  On  the  other  hand,  serum from mice with normal  C  titers, 
when interacted with immune precipitates or endotoxin,  generated  substantial R.  SNYDERMAN,  J.  K.  PHILLIPS,  AND  S.  E.  MERGENI-IAGEN  1137 
activity for  mouse  peripheral PMN.  These  data confirmed previous findings 
that  CS-deficient mouse  serum interacted with endotoxin or immune precipi- 
tates was deficient in generating chemotactic activity in vitro for rabbit PMN 
(7,  13). It is interesting to note that even "background" chemotactic activity 
in  untreated  C5-normal  serum  was  higher  than  that  of  CS-deficient  serum 
(Table liD. 
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FIO. 3.  Accumulation  of PMN in the peritoneal cavity of  CS-deficient and CS-normal 
mice treated with endotoxin. Mice were injected intraperitoneally  with 250 #g endotoxin and 
the peritoneal fluids were removed  at varying  times thereafter. Each point represents the 
mean PMN count of six mice. The standard deviation of the means of the CS-deficient and 
C5-normal mice at hours 3, 6, 12, and 24 did not overlap and the curves differ significantly 
(P <  0.01). 
These findings, taken  together with the observations that PMN  from both 
C5-deficient and  C5-normal  mice  responded normally to  chemotactic stimuli 
in vitro, indicated that  these two groups  of mice would make a  useful model 
for the in vivo study of the role of C5  in the kinetics of PMN  accumulation 
in inflammatory exudates. 
Kinetics  of  PMN Accumulation  in  Inflammatory  Exudates  in  CS-Deficient 
and C5-Normal Mice.--C5-deficient  and  C5-normal mice were  injected intra- 
peritoneally with  125  or 250 ~g of endotoxin. Neither of  these  doses resulted 
in significant mouse mortality for at least  24 hr after injection. Groups of six 
mice were sacrificed immediately or at  1,  3,  6,  12,  and  24 hr  after endotoxin 
injection.  Peritoneal  exudates  were  removed  and  the  total number  of PMN 1138  BIOLOGICAL  ACTIVITY  OF  COMPLEMENT  IN  VIVO 
in  the  exudates  was  determined  (Fig.  3).  A  significant  increase  in  the  ac- 
cumulated PMN  was noted in CS-normal mice as early as 3 hr after injection 
of endotoxin and the number of PMN  increased linearly during  the 24 hr test 
period. In contrast, mice defcient in C5 did not have  a  significantly increased 
number  of PMN  until 12 hr after injection and at no time in the 24 hr period 
did the numbers of PMN approach those found in C5-normal mice. 
In  other  experiments,  however,  exudates  were  collected  for  up  to  48  hr 
after injection of endotoxin.  In  C5-normal mice,  the numbers  of PMN  at 48 
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FIO. 4.  Chemotactic activity for  mouse  PMN  in  the peritoneal fluids of C5-deficient 
and CS-normal mice injected with endotoxin.  Mice were injected intraperitoneally with 250 
#g endotoxin and the peritoneal fluids were removed at varying times thereafter. Each point 
represents the chemotaetic activity of the pooled exudates of six mice. 
hr  were  approximately double  the  numbers  found  at  24  hr.  In  CS-deficient 
mice  the  numbers  of cells also increased markedly in  the  period between  24 
and 48 hr,  and approached (approximately 75 %)  the numbers of PMN  found 
in CS-normal mice. The differences in PMN  in the inflammatory exudates of 
C5-deficient versus  C5-normal mice  was  most  marked  (P  <  0.01)  from  3  to 
24 hr after injection of endotoxin. At 48 hr the difference in the two groups of 
mice was less pronounced (P  <  0.5). 
Chemotactic  Activity for  PMX  in  Peritoneal  Exudate  Fluid  of  Endotoxin- 
Treated  Mice.--Supernatants  of  peritoneal  exudates  from  endotoxin-treated 
mice were  tested  in vitro for  chemotactic activity at various  times after  in- 
jection  of  endotoxin.  PMN  derived  from  the  peripheral  blood  of  normal 
BALB/c mice served as the source of cells in these experiments. In C5-normal R.  SNYDERMAN,  J.  K.  PHILLIPS,  AND  S.  E.  MERGENHAGEN  1139 
mice,  marked  chemotactic  activity for  PMN  was  detected within  1  hr  after 
endotoxin injection (Fig. 4).  The  activity diminished gradually over a  24  hr 
period but was detectable as late as 24 hr  after endotoxin administration. In 
contrast, supernatants of CS-deficient mouse exudates contained no detectable 
chemotactic activity for  at  least 6  hr  and  at  12  and  24  hr  contained  barely 
detectable levels of activity. 
Characterization  of Chemotactic  Activity for PMN  in  the Peritoneal Fluid of 
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FIG. 5.  Characterization, by molecular  sieve chromatography, of chemotactic activity 
in supernatants derived from endotoxin-induced peritoneal exudates of C5-normal mice. Endo- 
toxin (125 #g) was injected into the peritoneal cavities of 10 C5-normal mice and the exudates 
were removed, centrifuged,  and pooled  1.5 hr thereafter. The exudate was concentrated six- 
fold and applied to a 2.5 X  50 cm Sephadex  G-100 column which had previously been cali- 
brated with BSA (tool wt 68,000) and cytochrome c (tool wt 12,500). PBS served as the elu- 
tion buffer. Fractions were tested for absorbance  (OD) at 280 m~ and for chemotactic activity 
for mouse PMN in vitro. 
Endotoxin-Treated  C5-Normal  Mice.--Endotoxin  (125  ~g)  was  injected  into 
the  peritoneal  cavities  of  10  C5-normal  mice  and  the  peritoneal  fluid  was 
removed 90 min later. The chemotactic activity in the supernatant fluid was 
heat stable (56°C for 30 min) and nondialyzable. A portion of the concentrated 
(6X)  cell-free  exudate  was  chromatographed  on  a  Sephadex  G-100  column 
(Fig. 5). A  sharp peak of chemotactic activity eluted just before a  cytochrome 
c marker (mol wt  12,500).  In addition, a  smaller peak  of  activity eluted  just 
after  the  void  volume  (tool  wt  >  150,000).  In  repeated  experiments  using 
exudates taken at 60 min-2 hr,  the heavier peak of activity was only variably 
found  and  never  accounted  for  more  than  50%  of  the  chemotactic  activity 
contained in the lower molecular weight peak. 1140  BIOLOGICAL  ACTIVITY  OF  COMPLEMENT  IN  VIVO 
DISCUSSION 
It is generally accepted that  the complement, kinin,  and  clotting  systems 
are important humoral mediators of the acute inflammatory response (1-3,  14). 
However,  evidence detailing  a  specific function related  to  the  mediation  of 
inflammation in vivo to any of these systems or component parts is fragmentary. 
While it is reasonable to expect that such humoral  effectors of inflammation 
function in  an  interrelated  and  synergistic  manner,  it  is  equally reasonable 
to expect that specific events in the inflammatory response might be mediated 
predominately by  specific  components  of  one  of  the  effector systems.  The 
accumulation  of PMN  in  inflammatory sites is  of major  significance to  the 
host for at least two reasons.  First,  the PMN  is intimately involved in host 
defense against microbial invasion and second, in certain inflammatory disease 
states,  the  PMN  appears  to be responsible for a  large degree of host-tissue 
destruction (15). Recognizing the importance of PMN accumulation in various 
pathophysiological states, studies were undertaken to elucidate the role of the 
complement  system  in  vivo  in  mediating  this  aspect  of  the  inflammatory 
response. 
PMN  used for in vitro studies  of chemotaxis have characteristically been 
obtained  from  the  peritoneal  cavities  of  animals  previously  injected  with 
glycogen (9). If chemotaxis was the mechanism by which PMN accumulated 
in the peritoneal cavity in response to glycogen, it was reasoned that a chemo- 
tactic factor for PMN  might  be  detectable in  the  peritoneal fluid.  Indeed, 
fluids removed from guinea pigs  at various  times after glycogen stimulation 
contained chemotactic activity for rabbit  PMN  in vitro. The appearance of 
this activity in vivo preceded the influx of PMN and diminished somewhat as 
the  number  of PMN  increased.  The reason for the  decrease of chemotactic 
activity  concurrently with  PMN  accumulation  has  not  yet  been  resolved. 
There was  substantial  evidence to  support  the notion  that  the  chemotactic 
activity derived from the peritoneal fluid was  generated in vivo rather than 
after removal from the animal. First, fluids were collected in sufficient EDTA 
to block activation  of  the  complement and  clotting  systems.  Second,  fluids 
were  immediately  brought  to  0°C  after  collection  and  could  be  heated  to 
56°C without a substantial loss of chemotactic activity. Third, neither glycogen 
nor  endotoxin alone was  chemotactic for  PMN  in  vitro.  These findings  in- 
dicated that the use of the peritoneal cavity as an in vivo model for the  study 
of inflammation might prove useful in studying the kinetics and mediators  of 
PMN infiltration. Injection of endotoxin into the peritoneal cavity of  guinea 
pigs proved to be similar to glycogen in that, shortly after injection, peritoneal 
fluids contained ehemotactic activity for PMN in vitro and this  activity was 
followed by the accumulation of PMN. 
The chemotactic activity derived from endotoxin-induced guinea pig peri- R.  SNYDERMAN,  J.  K.  PHILLIPS,  AND  S.  E.  MERGENHAGEN  1141 
toneal  exudates  was  characterized in  order  to  determine its  relationship  to 
previously  described  chemotactic  factors.  Chemotactically  active  exudate 
fluids  were  fractionated  by  molecular  sieve  chromatography  and  sucrose- 
density  gradient  ultracentrifugation.  In  all  instances,  the  majority  of  the 
chemotactic activity behaved similar to the CSa chemotactic factor (11,  12). 
In  some experiments, additional  activity was  detected and had  a  molecular 
weight > 68,000. The relationship of this high molecular weight activity to the 
C system is unknown at present. The low molecular weight chemotactic factor 
was isolated by gel filtration and tested for antigenic determinants in common 
with C5. The inhibition of this activity by antibody to  guinea pig C5  estab- 
lished its identity with C5a. 
In recent years a number of investigators have found the C5-deficient mouse 
to be a  useful tool for the study of the biological role of complement in vivo 
(16-19). Of particular interest were the findings that the C5-deficient animals 
were more  susceptible  to  certain  microbial infections  than  their  C5-normal 
counterparts (17-19). Since the PMN is of major importance in host defense 
against  microbial invasion,  studies were undertaken  to determine if animals 
lacking C5 were deficient in mobilizing PMN in response to an inflammatory 
stimulant. The data showed that the accumulation of PMN in response to a 
local  endotoxin  challenge  was  markedly  deficient in  mice  lacking  C5.  The 
abnormality was most dramatically seen within the first 24 hr after endotoxin 
injection.  The data  also  suggested  that  this  abnormality found in  the  C5- 
deficient mice was because of their inability to mobilize a PMN chemotactic 
factor which was  dependent upon the presence of C5. The evidence for this 
was that while CS-normal mice generated a PMN chemotactic factor in their 
peritoneal  fluid  before  the  accumulation  of  PMN,  the  C5-deficient  mice 
generated no substantial  PMN  chemotactic activity for the first 12 hr after 
endotoxin injection. Moreover, the PMN from C5-deficient mice were normal 
in their response in vitro to preformed chemotactic factors. Finally, the elution 
profile on Sephadex G-100 of the vast majority of chemotactic activity derived 
from peritoneal exudate fluids of C5-normal mice was strikingly similar to that 
of guinea pig and human C5a (12, 20). 
The present findings,  taken in  conjunction with  other studies  showing an 
increased  susceptibility of  C5-deficient mice  to  certain microbial infections, 
suggests  an  important  role  for  C5-dependent  chemotaxis  of  PMN.  Since 
phagocytosis  and  intracellular  killing  of  microorganisms  is  a  primary  pro- 
tective function of the PMN, the early local accumulation of these leukocytes 
at sites of microbial invasion would be expected to aid in the rapid destruction 
of microorganisms. Alternatively, a delay in the accumulation of PMN would 
allow  for  proliferation  and  perhaps  dissemination  of  microorganisms.  The 
marked deficiency in the rate of local accumulation of PMN in  C5-deficient 
mice in response to endotoxin was found to be related to an inability of such 1142  BIOLOGICAL ACTIVITk" OF  COMPLEMENT  IN  VlVO 
mice  to  liberate  a  CS-dependent  chemotactic  factor.  We  suggest  that  the 
deficiency  in  releasing  this  CS-dependent  chemotactic  activity  results  in  a 
deficient early accumulation of PMN locally and accounts, at least in part, for 
their increased susceptibility to infection. 
SUMMARY 
The  importance  of  C5  in  the  generation  of  complement  (C)-dependent 
chemotactic  activity  in  vitro  is  well  recognized.  However,  the  actual  role 
C5 may play in the accumulation of polymorphonuclear leukocytes (PMN)  at 
inflammatory sites in rive has not been established.  Injection of glycogen or 
endotoxin  into  the  peritoneal  cavities  of guinea  pigs  resulted,  shortly there- 
after, in  the local accumulation  of PMN.  Preceding the influx  of leukocytes, 
the peritoneal fluid became chemotactic for rabbit PMN in vitro. The majority 
of this activity could be attributed  to a  cleavage product of C5  (C5a).  Simi- 
larly,  injection  of  endotoxin  into  the  peritoneal  cavity  of  C5-normal  mice 
resulted in the generation of a  chemotacfic factor for mouse PMN which was 
followed  by the  accumulation  of  PMN  in  the  peritoneal  fluid.  In  contrast, 
injection of endotoxin into the peritoneal cavity of C5-deficient mice resulted 
in the generation of virtually no detectable chemotactic activity and a markedly 
depressed  accumulation  of  PMN  during  the  first  24  hr  after injection.  The 
data  suggest  that  C5  plays  an  important  role  in  the  early phases  of  PMN 
accumulation in response to inflammatory stimuli. The rapid accumulation of 
PMN  in  response  to  an  inflammatory stimulus  such  as  bacterial  endotoxin 
would  be expected  to be a  major factor in  host  defense against proliferation 
and dissemination of infectious agents. 
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